Quinolizidinyl derivatives of iminodibenzyl and phenothiazine as multidrug resistance modulators in ovarian cancer cells

Investigational New Drugs

Volumn 21, Issue 4, 2003, Pages 413-420

  Barbieri, Federica ^a   Alama, Angela ^a   Tasso, Bruno ^b   Boido, Vito ^b   Bruzzo, Cristina ^a   Sparatore, Fabio ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Chemosensitizers; Cytotoxicity; Iminodibenzyl derivatives; Ovarian cancer cells; Phenothiazine derivatives; Quinolizidinyl derivatives

Indexed keywords

BENZENE DERIVATIVE; BENZYL DERIVATIVE; CLOMIPRAMINE; DOXORUBICIN; GLYCOPROTEIN P; ISOPROTEIN; PHENOTHIAZINE DERIVATIVE; QUINOLIZIDINE DERIVATIVE;

ALKALINITY; ARTICLE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EXPOSURE; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IC 50; LIPOPHILICITY; MULTIDRUG RESISTANCE; OVARY CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; WESTERN BLOTTING;

BENZYLAMINES; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; OVARIAN NEOPLASMS; PHENOTHIAZINES; QUINOLIZINES;

EID: 1642452917     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026295017158     Document Type: Article

References (26)

1. Ford JM, Hait WN: Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 42: 155-199, 1990
2. Ling V: Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 40(suppl.): S3-S8, 1997
3. Sikic BJ, Fisher GA, Lum BL, Halsey J, Beketic-Oreskovic L, Chen G: Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. Cancer Chemother Pharmacol 40(suppl.): S13-S19, 1997
4. Geney R, Ungureanu M, Li D, Ojima I: Overcoming multidrug resistance in taxane chemotherapy. Clin Chem Lab Med 40: 918-925, 2002
5. Wiese M, Pajeva IK: Structure-activity relationship of multidrug resistance reversers. Curr Med Chem 8: 685-713, 2001
6. Teodori E, Dei S, Scapecchi S, Gualtieri F: The medicinal chemistry of multidrug resistance (MDR) reversing drugs. Farmaco 57: 385-415, 2002
7. Ford MJ, Prozialeck WC, Hait WN: Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance. Mol Pharmacol 35: 105-115, 1989
8. Ford JM, Bruggeman EP, Pastan I, Gottesman MM, Hait WN: Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines. Cancer Res 50: 1748-1756, 1990
9. Ramu A, Ramu N: Reversal of multidrug resistance by phenothiazines and structurally related compounds. Cancer Chemother Pharmacol 30: 165-173, 1992
10. Pajeva IK, Wiese M: QSAR and molecular modelling of catamphiphilic drugs able to modulate multidrug resistance in tumors. Quant Struct Act Relat 16: 1-10, 1997
11. Pajeva IK, Wiese M: Molecular modeling of phenothiazines and related drugs as multidrug resistance modifier: a comparative molecular field analysis study. J Med Chem 41: 1815-1826, 1998
12. Sparatore F, Boido V: Derivati di amminoalcoli e diammine naturali di interesse farmacologico. Nota III. Sintesi di derivati lupinilici di sistemi eterociclici trianellari. Ann Chim 54: 591-601, 1964
13. Boido V, Sparatore A: Chinolizidinil derivati di sistemi triciclici. Farmaco 37: 63-73, 1982
14. Sparatore A, Sparatore F: Preparation and pharmacological activities of 10-homolupinanoyl-2-R-phenothiazines. Farmaco 49: 5-17, 1994
15. Novelli F, Sparatore A, Tasso B, Sparatore F: Quinolizidinyl derivatives of 511-dihydro-6H-pyrido(2,3-b(-(1,4( benzodiazepin-6-one as ligands for muscarinic receptors. Bioorg Med Chem Lett 9: 3031-3034, 1999
16. 2 receptor subtypes. Farmaco, in press, 2003
17. Mazzoni A, Trave F: Cytoplasmic membrane cholesterol and doxorubicin cytotoxicity in drug-sensitive and multidrug-resistant human ovarian cancer cells. Oncol Res 5: 75-82, 1993
18. Häfliger F, Schindler W: N-Acyl derivatives of iminodibenzyl. US2, 666,051. Chem Abstr 49: 9041f, 1955
19. Ekstrand T: Phenothiazine derivatives of pharmacological interest. Acta Chem Scand 3: 302-303, 1949
20. Société des usines chimiques Rhone-Poulenc. Phenothiazine derivatives. Brit 740, 932. Chem Abstr 51: 500i, 1957
21. Kazutoshi F, Atsuo S, Kazuo S, Kazuo O: 10-Chloroacetyl phenothiazine. Japan 74 29, 19. Chem Abstr 82: 140161w, 1975
22. Toldy L, Toth I, Fekete M, Borsy J: Phenothiazine derivatives. VI. Experiments for the preparation of phenothiazines with selective coronary dilator activity. Acta Chim Acad Sci Hung 44: 301-325, 1965
23. Novelli F, Sparatore F: Thiolupinine and some derivatives of pharmacological interest. Farmaco 48: 1021-1049, 1993
24. Domenjoz R, Theobald W: Pharmacologie des Tofranil (N-(3- dymethylaminopropyl)-iminodibenzyl hydrochloride). Arch Int Pharmacodyn 120: 450-489, 1959
25. Tobe A, Yoshida Y, Ikoma H, Tonomura S, Kikumoto R: Pharmacological evaluation of 2-(4-methylaminobuthoxy)diphenylmethane hydrochloride, a new psychotropic drug with antidepressant activity. Arzneim Forsch 31: 1278-1285, 1981
26. Guan J, Kyle DE, Gerena L, Zhang Q, Milhous WK, Lin AJ: Design, synthesis and evaluation of new chemosensitizers in multi-drug resistant Plasmodium falciparum. J Med Chem 45: 2741-2748, 2002